Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation

Diabetic Medicine

Volumn 25, Issue 6, 2008, Pages 651-656

  D'Amato, E ^a   Tammaro, P ^b   Craig, T J ^b   Tosi, A ^c   Giorgetti, R ^c   Lorini, R ^a   Ashcroft, F M ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Galmarini Hospital   (Italy)

Author keywords

Diabetes mellitus; KCNJ11; Kir6.2; Neonatal diabetes; Type 2 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL; SULFONYLUREA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY; FEMALE; GENE ACTIVITY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HETEROZYGOSITY; HUMAN; IC 50; IMPAIRED GLUCOSE TOLERANCE; INFANT; MALE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PHENOTYPE; RAT;

ADULT; DIABETES MELLITUS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MUTATION; PEDIGREE; PHENOTYPE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PREGNANCY;

EID: 44649133877     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02443.x     Document Type: Article

References (19)

1. Ashcroft FM. The Walter B Cannon Lecture. ATP-sensitive K-channels and disease: from molecule to malady. Am J Physiol Endocrinol Metab 2007 293 : E880 E889.
2. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005 54 : 2503 2513.
3. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006 49 : 1190 1197.
4. Flanagan SE, Patch AM, Mackay D, Edghill EL, Gloyn AL, Robinson D et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007 56 : 1930 1937.
5. Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 2005 14 : 925 934.
6. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004 350 : 1838 1849.
7. Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005 25 : 22 27.
8. Yorifuji T, Nagashima K, Kurokawa K, Kaway M, Oishi M, Akazawa G et al. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus. J Clin Endocrinol Metab 2005 90 : 3174 3178.
9. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 2004 101 : 17539 17544.
10. Girard CJ, Shimomura K, Proks P, Absalom N, Castano L, Pérez de Nanclares G et al. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes. Plugers Archiv 2006 453 : 323 332.
11. Proks P, Arnold A, Bruining J, Girard C, Flanagan SE, Larkin B et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet 2006 15 : 1793 1800.
12. Ellard E, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A et al. Permanent neonatal diabetes caused by dominant, recessive or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 2007 81 : 375 382.
13. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006 355 : 456 466.
14. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP-sensitive K-channels in the absence of the sulphonylurea receptor. Nature 1997 387 : 179 183.
15. TP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003 52 : 568 72.
16. Schwanstecher C, Meyer U, Schwanstecher M. Kir6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K+ channels. Diabetes 2002 51 : 875 879.
17. Pearson ER, Flechtner I, Njølståd PR, Neonatal diabetes international collaborative group, Malecki MT, Flanagan S et al. The successful transfer of insulin treated patients with diabetes due to Kir6.2 (KCNJ11) mutations to sulphonylurea tablets. New Eng J Med 2006 355 : 467 477.
18. Gribble FM, Loussouarn G, Tucker SJ, Zhao C, Nichols CG, Ashcroft FM. A novel method for measurement of sub-membrane ATP concentration. J Biol Chem 2000 275 : 30046 30049.
19. TP channel Kir6.2 subunit. EMBO J 2005 24 : 229 239.